Menu visibility control



Startup Surgery

Most Recent

Government & Policy

UK tech reacts to the arrival of the Fourth EU Money Laundering Directive


Inbound investment into UK tech ‘reaches 10 year high’


Starling Bank expands to Ireland as it eyes Europe

Press Releases

‘Connected finance’ app Curve hits £50m spend ahead of UK launch
“Coffee, networking and productivity”: Workspace disruptor ‘Lounge’ launches in London
Kompli-Global’s Technology Will Make Life Harder for Money Launderers

Bristol-based Micrima raises £2.6m to improve breast screening


Micrima, a Bristol-based breast imaging tech company, has raised £2.6m in funding from pre-existing and new investors.

Founded in 2006, the company’s patented MARIA technology aims to make breast screening safer, more comfortable and more accessible to a larger proportion of the female population.

The round drew in support from re-investing shareholders including Technology Venture Partners LLP, Swarraton Partners, and the Angel CoFund. The University of Bristol Enterprise Fund has been welcomed as a new investor.

Tech in Bristol: A hub full of optimism

Roy Johnson, founder and executive chairman of Micrima, said: “Breast cancer is the most common cause of death in women between the ages of 35 and 55 in Europe and the leading cause of death for women in many countries. The problem is that many tumours are not discovered early enough, largely due to the difficulty in discriminating between cancers and dense tissue using current imaging technology.”

The firm says it will use the funding to support accelerated development of its MARIA technology, initially pioneered at the University of Bristol, with plans to start the commercialisation of its first system towards the end of this year.

“Using harmless radiowaves, the MARIA imaging system is capable of detecting tumours in dense tissue and allows routine and repeated scanning without any of the safety or comfort concerns associated with x-ray mammography. The process takes less than five minutes and avoids painful breast compression,” Johnson continued.

Tim Mills, investment director at the Angel CoFund, commented: “We originally invested in Micrima because we knew we’d found an extremely capable team working with some very interesting technology in a sector with considerable opportunity for innovation. The team has really delivered on our expectation in the last couple of years and we’re very happy to be supporting them again through this next phase of development.”

Enter your email address to receive updates straight to your inbox

* indicates required
Send me news on...

Editor's picks

UK tech reacts to the arrival of the Fourth EU Money Laundering Directive
posted 3 hours ago

Inbound investment into UK tech ‘reaches 10 year high’
posted 4 hours ago

Starling Bank

Starling Bank expands to Ireland as it eyes Europe
posted 8 hours ago

FinTech startup Yoyo Wallet gets £12m to expand across Europe
posted 10 hours ago

Survey: 22% of female tech founders not heard by male investors
posted 11 hours ago

man smiling at colleague

Your employer brand: How to be more attractive to tech professionals
posted on June 25, 2017